Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Tur-Kaspa

Showing results (91-100 of 146) with videos related to

Pageof 15
Sort By:
Transplantation Proceedings|June 17, 2000
Conversion of liver allograft recipients from cyclosporine A to FK 506 immunosuppressive therapyZ Ben-Ari, E Mor, E Shaharabani, et al.
Transplantation Proceedings|March 20, 2003
Combination hepatitis B immune globulin and lamivudine versus hepatitis B immune globulin monotherapy in preventing recurrent hepatitis B virus infection in liver transplant recipientsZ Ben-Ari, E Mor, N Bar-Nathan, et al.
Transplantation Proceedings|March 20, 2003
Comparison of tacrolimus with cyclosporin as primary immunosuppression in patients with hepatitis C virus infection after liver transplantationZ Ben-Ari, E Mor, N Bar-Nathan, et al.
Transplantation Proceedings|June 17, 2000
Combination of interferon-alpha and ribavirin therapy for recurrent hepatitis C virus infection after liver transplantationZ Ben-Ari, E Mor, E Shaharabani, et al.
Israel Journal of Medical Sciences|October 1, 1982
Non-A, non-B hepatitis not following transfusion: a study of hospital patients in JerusalemM Shalit, R Tur-Kaspa, R Adler, et al.
Scandinavian Journal of Gastroenterology|April 1, 1996
Esophageal malignancy after liver transplantation in a patient with Barrett's esophagusY Ilan, D Shouval, E Galun, et al.
Clinical and Experimental Immunology|April 1, 1981
Immunological evaluation of asymptomatic carriers of hepatitis B virusY Levo, D Shouval, R Tur-Kaspa, et al.
Digestive Diseases and Sciences|February 24, 2001
Mutations at vicinity of catalytic sites of hepatitis C virus NS3 serine protease gene isolated from hepatocellular carcinoma tissueR Zemel, A Kazatsker, F Greif, et al.
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 5, 1999
Posttransplantation lymphoproliferative disorder in liver recipients: characteristics, management, and outcomeZ Ben-Ari, P Amlot, S R Lachmanan, et al.
Annals of Neurology|September 1, 1981
Myeloma protein synthesis within the CNS by plasma cell tumorsT Siegal, J Shorr, I Lubetzki-Korn, et al.
Pageof 15

Showing results (91-100 of 146) with videos related to

Sort By:
Pageof 15
Transplantation Proceedings|June 17, 2000
Conversion of liver allograft recipients from cyclosporine A to FK 506 immunosuppressive therapyZ Ben-Ari, E Mor, E Shaharabani, et al.
Transplantation Proceedings|March 20, 2003
Combination hepatitis B immune globulin and lamivudine versus hepatitis B immune globulin monotherapy in preventing recurrent hepatitis B virus infection in liver transplant recipientsZ Ben-Ari, E Mor, N Bar-Nathan, et al.
Transplantation Proceedings|March 20, 2003
Comparison of tacrolimus with cyclosporin as primary immunosuppression in patients with hepatitis C virus infection after liver transplantationZ Ben-Ari, E Mor, N Bar-Nathan, et al.
Transplantation Proceedings|June 17, 2000
Combination of interferon-alpha and ribavirin therapy for recurrent hepatitis C virus infection after liver transplantationZ Ben-Ari, E Mor, E Shaharabani, et al.
Israel Journal of Medical Sciences|October 1, 1982
Non-A, non-B hepatitis not following transfusion: a study of hospital patients in JerusalemM Shalit, R Tur-Kaspa, R Adler, et al.
Scandinavian Journal of Gastroenterology|April 1, 1996
Esophageal malignancy after liver transplantation in a patient with Barrett's esophagusY Ilan, D Shouval, E Galun, et al.
Clinical and Experimental Immunology|April 1, 1981
Immunological evaluation of asymptomatic carriers of hepatitis B virusY Levo, D Shouval, R Tur-Kaspa, et al.
Digestive Diseases and Sciences|February 24, 2001
Mutations at vicinity of catalytic sites of hepatitis C virus NS3 serine protease gene isolated from hepatocellular carcinoma tissueR Zemel, A Kazatsker, F Greif, et al.
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 5, 1999
Posttransplantation lymphoproliferative disorder in liver recipients: characteristics, management, and outcomeZ Ben-Ari, P Amlot, S R Lachmanan, et al.
Annals of Neurology|September 1, 1981
Myeloma protein synthesis within the CNS by plasma cell tumorsT Siegal, J Shorr, I Lubetzki-Korn, et al.
Pageof 15